lytgobi
taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - antineoplastiske midler - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
reglone, reg.nr. 1-178 vandopløseligt koncentrat
syngenta nordics a/s - diquat, diquat - vandopløseligt koncentrat - 374 g/l diquat dibromid ; (~ 200 g/l diquat
plenum 50 wg vanddispergerbart granulat
syngenta nordics a/s - pymetrozin - vanddispergerbart granulat - 500 g/kg pymetrozin
armure emulsionskoncentrat
syngenta nordics a/s - difenoconazol, propiconazol - emulsionskoncentrat - 150 g/l difenoconazol ; 150 g/l propiconazol
shirlan suspensionskoncentrat
syngenta nordics a/s - fluazinam - suspensionskoncentrat - 500 g/l fluazinam
wakil xl vanddispergerbart granulat
syngenta nordics a/s - fludioxonil, cymoxanil, metalaxyl-m - vanddispergerbart granulat - 50 g/kg fludioxonil ; 100 g/kg cymoxanil ; 169 g/kg metalaxyl-m